Kalpesh V. Upadhye, Ph.D, is a registered patent lawyer focused on intellectual property matters with an emphasis on obtaining and defending patents. He helps clients with building and managing patent portfolios, drafting targeted claims, advising on trade secret issues, assessing patentability, and analyzing freedom to operate, infringement, and invalidity issues. Kalpesh also conducts due diligence analysis of patent portfolios in relation to mergers, acquisitions, and other transactions. Kalpesh’s clients include domestic and international corporations as well as universities.
With a background in physics and life sciences, Kalpesh has experience with subject matter in a wide variety of technical areas that intersect technology and life sciences, including biomaterials, drug delivery, biosensors, bioreactors, medical devices, semiconductors, photovoltaics, electronic and electromechanical components, lighting systems, telecommunications, navigation systems, autonomous vehicle systems, batteries, engineered materials, bulk metallic glasses, meta materials, magnetoresistive materials, and superconductors, as well as biotechnology.
Prior to joining Morgan Lewis, Kalpesh worked as a patent agent with another major general practice law firm. During his postdoctoral research, Kalpesh developed nonviral methods for nucleotide delivery into mammalian cells. Kalpesh’s doctoral thesis focused on the multiparametric investigation of mechanosensitive ion channels in mammalian cells and developing the tools required for such multiparametric investigation. Previously, Kalpesh developed MEMS-based point-of-care sensors for measuring cardiac markers in human blood for early diagnosis of myocardial infarction.
Kalpesh received his J.D. from the George Washington University Law School in 2019. Kalpesh has been a member of the patent bar since 2012. He is fluent in Hindi and Marathi.
Conducted patent prosecution for a Korean university for gene therapy and bioreactors
Conducted patent prosecution for a British university for hybrid adenoviral vectors
Conducted patent prosecution for a US university for antimicrobial compositions and gene therapy
Drafted patents and conducted prosecution for a California-based biopharmaceutical company for method of treatment with viral-based gene therapy
Conducted gene therapy patent landscape analysis for a California-based biopharmaceutical company
The George Washington University Law School, 2019, J.D., with Honors
University of Pittsburgh, 2010, Ph.D., Bioengineering
Indian Institute of Technology, 2002, B.Tech, Engineering Physics
District of Columbia
US Patent and Trademark Office
Awards and Affiliations
Member, Practice Group of the Year, Intellectual Property, Law360 (2019)
Member, American Bar Association
Member, American Intellectual Property Law Association (AIPLA)